This issue covers topics such as bariatric surgery, care for patients in an urban environment, and screening options for hepatitis C. ... Speaking of public health, hepatitis C virus (HCV) infection may be even more pervasive than reported, according to
Chronic hepatitis C may get a lot of press, but it isn't the most common chronic liver disease in the U.S. ... Torres, MD, told an audience of Internal Medicine Meeting 2016 attendees at her session, “Evolving Paradigms in Chronic Hepatitis.”.
The patient was a 44-year-old physician, working in the hepatitis section of the CDC. ... He further attributed the elevated ALT and AST to occupational exposure to hepatitis virus.
Hepatitis C virus antibody assay. D. HLA-B27 testing. E. Serologic testing for HIV antibodies. ... Patients with systemic lupus erythematosus (SLE) and hepatitis C virus infection may have musculoskeletal and cutaneous manifestations.
A recall of one lot of Recombivax HB hepatitis B vaccine adult formulation by Merck Sharp & Dohme Corp due to the potential for a limited number of cracked vials. ... The Abbott RealTime HCV Genotype II, the first test that identifies the genotype of
e.g., hepatitis C drugs that provide a cure but cost about $1,000 a pill), he said. ... Volpp said. "I think increasingly, you might see them used in cases like Sovaldi [sofosbuvir] for hepatitis C, where you have very expensive medications for a limited
Tenofovir disoproxil fumarate (Viread) for chronic hepatitis B in adults, with a recommended daily dose of 300 mg. ... Patients who discontinue Viread should be monitored closely for several months, as acute exacerbations of hepatitis have occurred in
This issue covers patients who record physician visits, early interventions for hepatitis B, and the use of standardized patients in medical education. ... Earlier intervention for hepatitis B virus (HBV) infection is vitally important but doesn't happen
Other drugs that he urged cautious enthusiasm about included telaprevir and boceprevir, FDA-approved for hepatitis C virus (HCV) last year. ... Knight. It's too early to guess the price on RG7128, a hepatitis C drug that doesn't even have a name yet, but
According to ACP Member Aaron M. Harris, MD, MPH, of the division of viral hepatitis at the CDC, research suggests that while prescribers are generally familiar with clinical practice guideline recommendations